Literature DB >> 8857721

Zoster myelitis: improvement with antiviral therapy in two cases.

S M de Silva1, A S Mark, D H Gilden, R Mahalingam, M Balish, F Sandbrink, S Houff.   

Abstract

This report describes two patients with acquired immunodeficiency syndrome (AIDS) and herpes zoster myelopathy. Patient one had a T-8 myelitis that preceded the onset of T-8-distribution zoster and was followed by cervical myelopathy. Antibody to varicella zoster virus (VZV) was present in the CSF. He never received steroids or other immunosuppressive drugs, and his condition improved dramatically after treatment with intravenous acyclovir. The second patient had a rapidly progressive myelitis with paralysis of both legs. Detection of VZV DNA and antibody to VZV in his CSF led to successful treatment with famciclovir despite discontinuation of dexamethasone and earlier treatment failure with acyclovir. These cases support the idea that VZV myelopathy in the immunosuppressed host is caused by virus invasion. CSF analysis for antiviral antibody and for VZV DNA by polymerase chain reaction are helpful in establishing the diagnosis. Aggressive antiviral therapy is advised.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857721     DOI: 10.1212/wnl.47.4.929

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  IVIG treatment for VZV-related acute inflammatory polyneuropathy in a child.

Authors:  Danilo Buonsenso; Benedetta Focarelli; Piero Valentini; Roberta Onesimo
Journal:  BMJ Case Rep       Date:  2012-07-19

Review 3.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 4.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

5.  Varicella Zoster Virus Induces Nuclear Translocation of the Neurokinin-1 Receptor, Promoting Lamellipodia Formation and Viral Spread in Spinal Astrocytes.

Authors:  Andrew N Bubak; Christina N Como; Anna M Blackmon; Seth Frietze; Teresa Mescher; Dallas Jones; Randall J Cohrs; Petr Paucek; Nicholas L Baird; Maria A Nagel
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

Review 6.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 8.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

9.  Recurrent varicella zoster virus myelopathy.

Authors:  Don Gilden; Maria A Nagel; Richard M Ransohoff; Randall J Cohrs; Ravi Mahalingam; Jody L Tanabe
Journal:  J Neurol Sci       Date:  2008-10-21       Impact factor: 3.181

10.  Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

Authors:  E Liana Falcone; Ademiposi A Adegbulugbe; Virginia Sheikh; Hiromi Imamichi; Robin L Dewar; Dima A Hammoud; Irini Sereti; H Clifford Lane
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.